Background illustration for clinical trials search

Paid Clinical Trials California

Discover 5,739 paid clinical trials in California. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1
Active & Responsive

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

for
Lymphoma, Non-Hodgkin, B-cell Lymphoma,
Location: Boston MA, New Haven CT, New York NY, Philadelphia PA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07101328

Phase1, Recruiting
Active & Responsive

Zanzalintinib for Metastatic Clear Cell Renal Cell Carcinoma With Bone Metastases

for
Clear Cell Renal Cell Cancer (ccRCC),
Location: San Francisco CA
Sponsor: Kelly Fitzgerald, MD

Sex: All

Age: 18+

Code: NCT07043608

Phase2, Recruiting
Active & Responsive

Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

for
Stroke, Hemorrhagic Stroke
Location: New York NY, Jacksonville FL, Houston TX,
Sponsor: EMVision Medical Devices Ltd

Sex: All

Age: 22+

Code: NCT06999122

Recruiting
Active & Responsive

SONATA LIFU for OCD

for
Obsessive Compulsive Disorder
Location: San Francisco CA
Sponsor: University of Pennsylvania

Sex: All

Age: 22 - 70+

Code: NCT07728994

Phase2, Recruiting
Active & Responsive

A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity

for
Adults With Overweight/Obesity and Type 2 Diabetes
Location: Hollywood FL, Savannah GA, Tampa FL, Decatur GA,
Sponsor: Antag Therapeutics

Sex: All

Age: 18+

Code: NCT07724340

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer

for
Colorectal Cancer
Location: East Brunswick NJ, Charlottesville VA, Tampa FL,
Sponsor: Verastem, Inc.

Sex: All

Age: 18+

Code: NCT07659795

Phase2, Recruiting
Active & Responsive

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

for
Unresectable or Metastatic Hepatocellular Carcinoma,
Location: Atlanta GA, Peoria IL, Los Angeles CA
Sponsor: CatalYm GmbH

Sex: All

Age: 18 - 70+

Code: NCT07219459

Phase2, Recruiting
Active & Responsive

A Study of ARC-02 in B-cell NHL

for
B-cell Non Hodgkin Lymphoma
Location: Spokane WA, Los Angeles CA
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07691606

Phase1, Recruiting
Active & Responsive

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease

for
Graves' Disease, Graves Disease
Location: New York NY, Fort Lauderdale FL, Kissimmee FL,
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07570316

Phase3, Recruiting
Active & Responsive

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

for
Alzheimer Disease
Location: Albany NY, Aventura FL, Miami FL, Hialeah FL,
Sponsor: Alpha Cognition, Inc

Sex: All

Age: 50+

Code: NCT07633470

Recruiting
Active & Responsive

A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment

for
Lung Non-Small Cell Carcinoma
Location: Bath ME, Brunswick ME, Portland ME, Scarborough ME,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT07293247

Phase2, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

for
Pulmonary Arterial Hypertension
Location: Philadelphia PA, Rochester NY, Anderson SC,
Sponsor: Insmed Incorporated

Sex: All

Age: 18 - 70+

Code: NCT07481981

Phase3, Recruiting
Active & Responsive

Preventing Medication Mismanagement in People Living With Dementia

for
Dementia
Location: Folsom CA
Sponsor: HiDO Technologies

Sex: All

Age: 65+

Code: NCT07600684

Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

for
Hyperphosphatemia,
Location: Orange CT, Middlebury CT, Ridgewood NY, Norfolk VA,
Sponsor: R1 Therapeutics

Sex: All

Age: 18+

Code: NCT06712654

Phase2, Recruiting
Active & Responsive

Open Label Study for the Use of Low Intensity Focused Ultrasound for Essential Tremor

for
Essential Tremor
Location: Los Angeles CA
Sponsor: University of California, Los Angeles

Sex: All

Age: 18 - 70+

Code: NCT07599592

Early_phase1, Recruiting
Active & Responsive

A Study of Rebecsinib for Patients With Relapsed/Refractory Secondary Acute Myeloid Leukemia or High Risk Myelofibrosis

for
Secondary AML, Myelofibrosis
Location: San Diego CA, Duarte CA, Sacramento CA
Sponsor: Aspera Biomedicines, Inc.

Sex: All

Age: 18+

Code: NCT07250646

Phase1, Recruiting
Active & Responsive

A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies

for
Solid Tumors
Location: St. Petersburg FL, Germantown TN, Rochester MN,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT07415031

Phase2, Recruiting
Active & Responsive

A Phase 2 Safety, Tolerability, PK, and Efficacy Study of CS-1103 Following Fentanyl Challenge With Naloxone Blockade

for
Fentanyl Overdose, Fentanyl Poisoning
Location: Glendale CA
Sponsor: Clear Scientific, Inc.

Sex: All

Age: 18 - 55

Code: NCT07459166

Phase2, Recruiting
Active & Responsive

A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)

for
Non-small Cell Lung Cancer
Location: New Haven CT, White Plains NY, Albany NY, Montreal,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07513376

Phase3, Recruiting
Active & Responsive

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease

for
Late-onset Pompe Disease
Location: Fairfax VA, Durham NC, St Louis MO, Irvine CA
Sponsor: Denali Therapeutics Inc.

Sex: All

Age: 18 - 70+

Code: NCT07354724

Phase1, Recruiting

Popular cities in California

With its extensive healthcare system and world-class medical research institutions, California is a major hub for clinical trials. Leading research centers such as UCLA Health, Stanford Medicine, the University of California, the City of Hope, San Francisco (UCSF), and the Scripps Research Institute are spearheading medical research and innovation. These institutions are at the cutting edge of clinical studies, driving advancements in groundbreaking treatments and significantly contributing to healthcare innovations across the state.

Why choose California for clinical trials?

The state of California offers a variety of benefits for participants in clinical trials. Firstly, because the state is home to leading research institutions, it provides participants with access to cutting-edge treatments and advanced medical technologies before they become widely available. These institutions are equipped with state-of-the-art facilities and staffed by top experts, ensuring high-quality care and rigorous monitoring throughout the study.

California's diverse and innovative research landscape offers a wide range of study options, enhancing the likelihood of finding a trial that matches specific health needs. Moreover, the state's adherence to stringent regulatory and ethical standards ensures that trials are conducted with the utmost integrity and participant protection.

Common conditions studied in California

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in California